| 国产齐拉西酮与利培酮治疗精神分裂症的对照研究 |
| |
| 引用本文： | 刘丽华,董玉霞,岳德华.国产齐拉西酮与利培酮治疗精神分裂症的对照研究[J].黑龙江医药科学,2011,34(5):18-19. |
| |
| 作者姓名： | 刘丽华 董玉霞 岳德华 |
| |
| 作者单位： | 青岛市精神卫生中心,山东青岛,266034 |
| |
| 摘 要： | 目的:以利培酮为对照,探讨齐拉西酮治疗精神分裂症的疗效和安全性.方法:将70例符合CCMD-3诊断标准的精神分裂症病人随机分为两组,分别给予齐拉西酮和利培酮治疗8周.于治疗前和治疗后2、4、8周末采用阳性症状和阴性症状量表(PANSS)评定临床疗效,副反应量表(TESS)评定副反应.结果:治疗8周后,两组疗效近似(P＞...
|
| 关 键 词： | 齐拉西酮 利培酮 精神分裂症 疗效 |
Zipraside and risperidone for Schizophrenia: A comparative study |
| |
| LIU Li-hua,DONG Yu-xia,YUE De-hua.Zipraside and risperidone for Schizophrenia: A comparative study[J].Heilongjiang Medicine and Pharmacy,2011,34(5):18-19. |
| |
| Authors: | LIU Li-hua DONG Yu-xia YUE De-hua |
| |
| Affiliation: | LIU Li-hua,DONG Yu-xia,YUE De-hua(Qingdao Mental Health Center,Qingdao 266034,China) |
| |
| Abstract: | Objective: To investigate the clinical efficacy and side effects of zipraside with risperidone as a control in the treatment of schizophrenia.Methods:A tota1 of 70 cases meeting the criteria of CCM D-3 for schizophrenia were randomly assigned to two group treated with zipraside(zipraside group) or risperidone(risperidone group)for 8 weeks.The positive and negative symptoms scale(PANSS)and treatment emergent symptoms scale(TESS)were used to evaluate the efficacy and adverse effects before treatment and at th... |
| |
| Keywords: | zipraside risperidone schizophrenia curative effect |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
